Leading Japanese pharmaceutical company, Takeda, inaugurated its regional headquarters (Takeda Pharmaceuticals Asia) and regional clinical coordination centre (Takeda Clinical Research Singapore) in Singapore.

“Takeda Pharmaceuticals Asia Private Limited will accelerate the commercial growth and reach of Takeda in the Asia Pacific region,” said Mr. Stefan Ziegler, Chief Executive Officer, Takeda Pharmaceuticals Asia Private Limited.  “Takeda Pharmaceuticals Asia Private Limited has chosen Singapore as its base due to its strong fundamentals for business and talent development in the pharmaceutical/biotechnology industry.  I look forward to building a team of professionals, dedicated to promoting healthcare and patient welfare in the region through Takeda’s innovative products.”

“Takeda Clinical Research Singapore Private Limited believes that the world-class talent available in Singapore will enable Takeda to manage and realize global quality clinical development in the Asia-Pacific region,” said Dr. Steve Coles, General Manager, Takeda Clinical Research Singapore Private Limited.  “Through our activities, we will not only raise regional awareness of Takeda’s integrity toward clinical science but also awareness of Takeda among the Asian medical community.”

“Takeda’s inauguration of its regional headquarters and regional clinical coordination centre in Singapore will deepen Takeda’s R&D roots in Singapore, strengthen the company’s presence in Asia and enhance its global reach. These investments will contribute PMET positions to the 900 jobs that the biomedical sciences sector in Singapore is projected to create this year,” said Mr Lim Swee Say, Minister, Prime Minister’s Office and Secretary-General, National Trades Union Congress. “Leading Japanese companies, such as Takeda, are keen to attract and nurture global talent to realise their global aspirations. In this respect, Singapore, as a global city in Asia, can play a role in talent development."